Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that Mr. William R. Keller has been appointed a Director of Alexion, effective ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE